AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Method of Diagnosing AlzheimerΓÇÖs Disease using Biomarkers

Technology Benefits

Patients can be treated early, possibly before cognitive symptoms are evident Provides more consistent and reliable data for relative protein quantification

Technology Application

detection of biomarkers for AlzheimerΓÇÖs disease

Detailed Technology Description

Our researchers have created a process for diagnosing, treating and determining pathology of AlzheimerΓÇÖs disease using novel biomarkers in the patientΓÇÖs own dermal fibroblasts. Once diagnosed using these newly identified biomarkers, patients can be treated early, possibly before cognitive symptoms are evident. A method of detecting biomarkers for AlzheimerΓÇÖs disease was also developed that uses SILAC-based proteomic analysis and mass spectrometry. This technique compared protein expression profiles of APP , rat neuronal-like B103 cells to B103-695 cells that express the APP isoform APP-695 in order to identify several proteins with potential implications in AD pathology. Protein expression levels may also indicate increased progression of the disease.

Country/Region

USA

For more information, please click Here